Natural history study of RYR1-related disorders
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study follows people with RYR1-related disorders over time to learn how the condition progresses. It may help researchers plan future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 7 years old.
- You must have a confirmed RYR1 genetic mutation found through standard testing.
- You must live in the United States.
- You must be able to walk 10 meters (about 33 feet) with or without help.
- You cannot be on a breathing machine or have a tracheostomy.
- You cannot have another muscle disease that causes weakness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with unusual or rare heart problems, or people with a family history of these issues. Doctors and researchers may collect and study your blood or tissue (and possibly store samples) to learn what causes the condition and how it may affect the heart.
This study tracks changes in muscle strength and breathing over time in people with certain types of muscular dystrophy. It helps researchers develop better tests to measure how the disease progresses.
This research study evaluates people with inherited neurological conditions (nervous system disorders that run in families) and their relatives. Researchers aim to better understand these conditions and improve diagnosis through clinical exams and genetic testing.
This study looks at people with RYR1-related conditions like muscle weakness or malignant hyperthermia. The goal is to learn more about these conditions and how common they are.
This study creates a registry for people with rare changes in the RYR2 gene that affect heart function. Researchers will collect information to better understand these conditions and improve care.
This trial tests whether a new drug called Surlorian can improve muscle strength in adults with a rare genetic muscle condition (RYR1-related myopathy). You'd receive either the drug or a placebo and be monitored for safety and changes in muscle function.
Hear when a new Ryanodine Receptor 1-Related Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.